Meteen naar de inhoud

Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia's NVentures (Kyt Dotson/SiliconANGLE) 19-10-2024

Kyt Dotson / SiliconANGLE:
Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia’s NVentures  —  Terray Therapeutics, a biotechnology company using artificial intelligence to accelerate the development of small-molecule drugs …


Lees verder op Tech Meme